@humain222 @Domibeu @LeBigChatain666 @laurenceide69 @BigD24177 @LaporteCaroli C'est de l'ordre de 50% (vaccin 2023-24), avec une baisse progressive. Mais ça reste toujours mieux qu'une efficacité de ZERO %. C'est comme la dette, c'est mieux de la réduire…
@PaulRic56123559 Clinical studies on this are hard to come by, as you can imagine. They often come out long after the fact because of the time it takes to accumulate data. Here is one I have seen recently, but there are others. https://t.co/GsgsX17D3Y
RT @skepticalIDdoc: Not a surprise to those of us who know the beneficial effects of #COVID19 vaccination, but the 🇨🇦 “vaccine gap” waiting…
Trending on PubMed: Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18,… https:/…